Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.2%

1 terminated/withdrawn out of 83 trials

Success Rate

97.8%

+11.3% vs industry average

Late-Stage Pipeline

11%

9 trials in Phase 3/4

Results Transparency

4%

2 of 45 completed trials have results

Key Signals

14 recruiting2 with results

Enrollment Performance

Analytics

N/A
41(75.9%)
Phase 4
6(11.1%)
Phase 2
3(5.6%)
Phase 3
3(5.6%)
Phase 1
1(1.9%)
54Total
N/A(41)
Phase 4(6)
Phase 2(3)
Phase 3(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (83)

Showing 20 of 83 trials
NCT07556094Not ApplicableCompleted

Empagliflozin and CPAP in Adults With Heart Failure and Obstructive Sleep Apnea.

Role: lead

NCT04789057Phase 4Active Not Recruiting

Atorvastatin Effect on Reduction of COPD Exacerbations

Role: lead

NCT07541378Not ApplicableSuspended

Comparative Efficacy of Once-daily LAMA/LABA Combinations Versus Tiotropium on Constant-work-rate Cycle Endurance in COPD

Role: lead

NCT07529379Not ApplicableRecruiting

Breathwork and Stress: Investigating the Mechanisms of Action and Effectiveness of Breathing Interventions in Modulating the Psychophysiological Response to Acute Stress Test

Role: lead

NCT07536737Not ApplicableCompleted

Impact of PDT and Topical Corticosteroids on Taste Perception in Patients With OLP

Role: lead

NCT04634591Recruiting

The Bialystok Bariatric Surgery Study

Role: lead

NCT04634890Not ApplicableCompleted

Bialystok Exercise Study in Diabetes

Role: lead

NCT07529145Recruiting

Cardiopulmonary Exercise Testing in Lung Cancer Patients Before and During Oncological Treatment

Role: lead

NCT07529132Recruiting

Changes in Energy Expenditure in Response to Physical Activity in Healthy Adults

Role: lead

NCT07498231Not ApplicableRecruiting

COronoary Microcirculation Analysis NETwork

Role: lead

NCT07496957Not ApplicableRecruiting

Preserflo MicroShunt Versus Trabeculectomy

Role: lead

NCT05182658Phase 3Active Not Recruiting

Empagliflozin in Hypertrophic Cardiomyopathy

Role: collaborator

NCT07324252Completed

Small RNA Profiling in EBC in Athletes

Role: lead

NCT06891092Not ApplicableRecruiting

Vivinex Impress XY1-EM vs RayOne EMV

Role: lead

NCT07325552Not ApplicableRecruiting

iStent Inject Versus Goniotomy With Kahook Dual Blade in Glauocma Treatment

Role: lead

NCT07232550Not Yet Recruiting

Biomarkers and Respiratory Omics as New CHildren Opportunities - Study of Clinical Outcomes and Predictivity Evaluation

Role: collaborator

NCT07027137Not ApplicableActive Not Recruiting

The Influence of Local Antibiotic Therapy on the Outcomes Following Periodontal Regeneration Procedures.

Role: lead

NCT04705337Phase 4Terminated

Levosimendan In Ambulatory Heart Failure Patients

Role: lead

NCT05467033Phase 3Recruiting

Safety Outcomes Post Kidney Biopsy - Randomized Clinical Evaluation of Efficacy of Desmopressin

Role: lead

NCT05582876Not ApplicableRecruiting

Multicenter Assessment of Clinical Utility PET / MR With the Use of the Radiotracer 68Ga-PSMA-11 in Therapy Planning Personalized in Patients With Prostate Cancer

Role: lead